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Abstract: General practitioners (GPs) play a key role in the timely diagnosis of dementia and also in
advance care planning (ACP). They often have known patients and their families for decades and are
familiar with their values and treatment preferences; they are, therefore, in a position to initiate the ACP
process even before the appearance of the first symptoms of dementia and certainly following disclosure
of the diagnosis. To do so, they should recognise whether patients are receptive to an ACP consultation
or whether they might reject it for personal, social or cultural reasons. Under no circumstances should
the patient or their family be coerced into making these provisions. In most countries, the current
framework does not provide enough time and money for GPs to carry out actual ACP consultations
completely on their own. There is evidence that specially trained health professionals are able to more
effectively discuss treatment goals and limits of life-prolonging measures than GPs who are well acquainted
with their patients. Consequently, we suggest that it will be the GPs’ task to seize the right moment
for starting an ACP process, to raise awareness of patients and their relatives about ACP, to test the
patient’s decision-making capacity and, finally, to involve appropriately trained healthcare professionals
in the actual ACP consultation process. Care should be taken that these professionals delivering time-
intensive ACP consultations are not only able to reflect on the patient’s values but are also familiar with
the course of the disease, the expected complications and the decisions that can be anticipated. The GP
will ensure an active exchange with the ACP professional and should have access to the documentation
drawn up in the ACP consultation process (treatment plan and advance directive including instructions
for medical emergencies) as soon as possible. GPs as coordinators of healthcare provision should document
appropriately all specialists involved in the care and ensure that treatment decisions are implemented in
accordance with the patient’s preferences for future care or the presumed will of the patient.
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Abstract
General practitioners (GPs) play a key role in the timely diag-
nosis of dementia and also in advance care planning (ACP). 
They often have known patients and their families for decades 
and are familiar with their values and treatment preferences; 
they are, therefore, in a position to initiate the ACP process 
even before the appearance of the first symptoms of dementia 
and certainly following disclosure of the diagnosis. To do so, 
they should recognise whether patients are receptive to an 
ACP consultation or whether they might reject it for personal, 
social or cultural reasons. Under no circumstances should the 
patient or their family be coerced into making these provi-
sions. In most countries, the current framework does not pro-
vide enough time and money for GPs to carry out actual ACP 
consultations completely on their own. There is evidence that 
specially trained health professionals are able to more effec-
tively discuss treatment goals and limits of life-prolonging 
measures than GPs who are well acquainted with their pa-
tients. Consequently, we suggest that it will be the GPs’ task to 
seize the right moment for starting an ACP process, to raise 
awareness of patients and their relatives about ACP, to test the 
patient’s decision-making capacity and, finally, to involve ap-
propriately trained healthcare professionals in the actual ACP 
consultation process. Care should be taken that these profes-
sionals delivering time-intensive ACP consultations are not 
only able to reflect on the patient’s values but are also familiar 
with the course of the disease, the expected complications 
and the decisions that can be anticipated. The GP will ensure 
an active exchange with the ACP professional and should have 
access to the documentation drawn up in the ACP consulta-
tion process (treatment plan and advance directive including 
instructions for medical emergencies) as soon as possible. GPs 
as coordinators of healthcare provision should document ap-
propriately all specialists involved in the care and ensure that 
treatment decisions are implemented in accordance with the 
patient’s preferences for future care or the presumed will of 
the patient. © 2019 S. Karger AG, Basel
Introduction
As the world population is aging, the number of peo-
ple diagnosed with dementia will increase over the next 











































































(WHO), a total of 35.6 million people were living with 
dementia in 2015. We can assume that this figure will 
double by 2030, and by 2050 it is likely to triple [1]. Gen-
eral practitioners (GPs) have a key role to play in this 
context, in both stating and communicating a diagnosis 
[2].
Disclosing the Diagnosis as a Precondition for 
Advance Care Planning
It is known that GPs often shy away from disclosing 
a diagnosis of dementia to a patient and are reluctant 
to talk about the problems associated with dementia 
with the patient’s family [3, 4]. Nevertheless, when talk-
ing to patients and their relatives, GPs are ethically and 
legally well advised to anticipate events that can be ex-
pected as the dementia progresses. This concerns par-
ticularly experiences of loss, such as the realisation that 
patients at some point may no longer be able to care for 
themselves or even follow conversations. In the USA, 
states of incapability of decision-making are regulated 
by the Patient Self-Determination Act [5]. In Switzer-
land, the law on the protection of adults was introduced 
in 2013. In line with the beforementioned legal frame-
works, the adult protection law is also driven by the 
intention to strengthen patient autonomy [6]. In addi-
tion, we know today that the majority of patients prefer 
an early communication of a diagnosis of dementia by 
their GP [7].
Approaches to Improved Early Detection of 
Dementia
In order for GPs to facilitate the advance care planning 
(ACP) process, they first of all must recognise symptoms 
of dementia and be able to talk about them with the pa-
tient and their relatives (Fig.  1). Pentzek et al. [8] per-
formed a meta-synthesis of qualitative studies with GPs 
on barriers to dementia recognition and developed an ap-
proach in cases of suspected cognitive decline in a multi-
professional team. With respect to recognition of and di-
agnostic approach to dementia, 3 major barriers were de-
tected: 
 − GPs often miss the opportunity to involve their pa-
tients in diagnostic decisions: i.e., it is left to the GP 














































Fig. 1. Advance Care Planning (ACP) for 
people with dementia – the role of general 
practitioners (GPs) – Key messages. Sourc-













































































 − GPs often confound diagnostic steps: i.e., GPs equate 
early recognition of cognitive decline with specialized 
dementia diagnostics or with the disclosure of proba-
ble dementia. Thus, GPs may feel uncomfortable talk-
ing about dementia.
 − GPs show a poor self-conception of diagnostic special-
ties and advantages in their GP setting. 
Based on these results, the authors developed an inter-
vention model called the CADIF project (Changing At-
titudes towards Dementia in Family Practice). The pro-
posed concept for a transfer into practice emphasises:
 − an increased awareness for cognitive warning signs 
(red flags) among practice personnel, initially inde-
pendently from test diagnostics;
 − a geriatric and personal approach to the patient, offer-
ing, for example, medication check and home visits; 
and
 − offering follow-up assessments and monitoring, re-
specting the patient’s refusal of further diagnostic pro-
cedures or planning a disease-oriented diagnosis [9].
Such and other efforts to sensitise GPs to this problem 
seem gradually to be successful. We have been able to 
show in a survey among Swiss GPs that they feel confident 
about diagnosing patients with dementia (except for pa-
tients from a migrant background), that they make these 
diagnoses at a relatively early stage of the illness, and that 
– since the efficacy of pharmacological therapy is largely 
inconclusive – they consider it important not to start drug 
treatment but provide advice to patients and their fami-
lies and help them write advance directives at an early 
stage of the illness [10].
ACP in the Context of Dementia
According to recent consensus definitions [11, 12], 
ACP is a continuing, dynamic process of reflection and 
discussion between patients, relatives and healthcare pro-
fessionals, which allows patients, depending on the stage 
of their illness, to communicate their values and treat-
ment preferences that are important for their further care 
and particularly for emergency and end-of-life decisions. 
Alongside this communication process, documenting the 
content of the discussions about values and treatment 
preferences in a standardised and medically meaningful 
way, especially with regard to the desired approach in sit-
uations of emergency, are key elements of ACP. It should 
also be mentioned at this point that an ACP process has 
not to be waived when a patient has lost the decision-
making capacity. “ACP by proxy” is an ethically justified 
concept, in which healthcare professionals and the pa-
tient’s surrogate establish and document the presumed 
wishes and treatment preferences of the person for an-
ticipated scenarios [13].
ACP Reduces Burden and Stress on Patients and 
Caregivers
If ACP is undertaken correctly and by appropriately 
trained professionals, it can help patients maintain au-
tonomy, dignity and intimacy when their health declines 
and at the end of their life; it helps relatives to experience 
the grieving process with less morbidity; and there are 
also hints that ACP has the potential to reduce inappro-
priate, unwanted hospital admissions and promote more 
cost-effective use of healthcare resources [14]. It should 
be stressed, however, that healthcare workers should sen-
sitively explore whether a patient is receptive to the idea 
of an ACP consultation or whether they might reject it for 
personal, social or cultural reasons. Under no circum-
stances should the patient or their family be coerced into 
making these provisions.
ACP in the Face of Diminishing Decision-Making 
Capacity
In general, it is assumed that people with dementia lose 
their capacity to make informed decisions more or less 
rapidly [15]. Therefore, a time- and decision-specific cog-
nitive and functional assessment is essential to evaluate 
the decisional capacity as part of a high-quality, continu-
ous ACP process. For this evaluation, GPs often intui-
tively rely on the criteria explicitly formulated by Grisso 
and Appelbaum [16], i.e.:
 − ability to understand information in relation to deci-
sions to be made;
 − ability to appreciate the situation and the consequenc-
es of alternative possibilities;
 − ability to weight the information received in a rational 
way in the context of a coherent value system; and
 − ability to communicate the own choice.
GPs are generally not trained to make a more in-depth 
clinical or neuropsychological assessment. They must en-
sure that they do not overestimate the decision-making 
capacity of their patients because of the longstanding and 
very personal doctor-patient relationship [17]. It is, there-
fore, essential to have such conversations at comparative-











































































anticipatory decisions in good time and communicate 
their values and treatment preferences to both relatives 
and treating physicians [18]. However, there are several 
barriers on different levels concerning the implementa-
tion of this evaluation process in practical everyday life:
 − People have difficulties talking about severe illness, dy-
ing and death in comparatively healthy days. 
 − Surrogates and professionals may feel unsure talking 
about anticipated decisions that could affect the pa-
tient’s life expectancy [19].
 − Professionals do not consider dementia as a terminal 
illness [20] with a life expectancy of dementia usually 
estimated as 3–12 years [21].
Although families and clinicians judge dementia as a 
progressive and incurable disease, the terminal event – 
often pneumonia or urinary tract infection – is consid-
ered unrelated to dementia and the cause of death.
Precisely because of the above-mentioned barriers, 
people with dementia are a particularly important target 
group for ACP. Considering the increasing aging of the 
population, many families will accompany a member 
with dementia. Particularly difficult ethical questions 
may arise due to conflicts between previously expressed 
preferences of the patient and their current behaviour, 
especially in cases of personality change.
Who Should Initiate ACP for People with Dementia?
In Central Europe, it is only in the last 10 years that 
there have been attempts to implement ACP in very dif-
ferent ways and among very different populations, in-
volving different healthcare specialists, while the major-
ity of scientific studies on ACP, including systematic re-
views, have been performed in the USA, Canada, the UK, 
Australia and New Zealand, countries with a tradition of 
ACP sometimes dating back more than 20 years. Regard-
ing the role distribution, there might, therefore, be differ-
ences important for a successful ACP implementation 
due to different healthcare structures and professional 
roles. Yet, there is now an international consensus that:
 − healthcare professionals should inform patients and 
their families about the possibility of ACP;
 − a trained non-physician facilitator is able to support an 
individual in the ACP process;
 − initiation of ACP can occur within or outside of the 
healthcare setting; and
 − appropriate healthcare providers are needed for clini-
cal elements of ACP, such as discussing diagnosis, 
prognosis, treatment and care options [12].
ACP Should Be Implemented and Regulated on the 
Level of Healthcare Systems
Besides necessary skills and structures on the micro-
level, recently, the importance of system approaches and 
regulations on the meso- and macrolevel of institutions, 
regions and national structures to support ACP is consid-
ered as a necessary precondition for high-quality ACP 
programmes. It is important that consistent regulations 
should be in place for a whole healthcare system on when 
ACP should begin, who should be empowered to do so 
and in what framework ACP should take place.
An expert task force set up by the Swiss Federal Office 
of Public Health has recommended that people at com-
paratively healthy stages should be asked, e.g., by their 
GP, about their values and treatment preferences and that 
they should be supported to voluntarily initiate an ACP 
process together with an appropriately trained profes-
sional [22]. Depending on the content of the consulta-
tion, this professional should have a deep understanding 
of ACP-relevant concepts. This includes a primary root-
ing of the whole advance care plan on individualised goals 
of care – rather than single disease-specific measures – 
and differentiating therapeutic goals for the relevant situ-
ations of incapability of decision-making (i.e., emergen-
cy, situations of acute disease with unclear prognosis and 
chronic states of incapability of decision-making). In ad-
dition, more specific medical knowledge to anticipate, in 
conversation with the patient, certain situations that can 
be expected in the course of the disease is helpful to spec-
ify, for example, an individualised emergency plan with 
the physician.
The Role of GPs in Facilitating the ACP Process 
This raises the question about the role of GPs in facili-
tating the ACP process, in carrying out time-consuming 
ACP consultations and in documenting the results of this 
process. Often, it will be the GPs’ task to translate the ap-
propriate values and treatment preferences into concrete 
medical decisions and measures as the illness progresses. 
GPs will frequently also be the link to the relatives of the 
affected person, either informally or in a planned way. As-
suming that a caregiver is generally integrated into the 
ACP process, it is also part of the GP’s role, if the patient 
gives his/her consent to involve the wider family, to create 
an understanding about the course of the illness and the 
decisions made by the patient and, finally, to recognise the 













































































If a person with dementia is no longer able to commu-
nicate verbally, GPs can help understand the emotional 
expressions of the patient and adapt treatments accord-
ingly. Ideally, the significance of emotional statements in 
advanced stages of the disease should already be recog-
nised and discussed in the early ACP process. Concretely, 
the patient may specify whether they would prioritise fu-
ture behavioural signs of wellbeing (and hence life-pro-
longing treatment) over advance refusals of care, or the 
reverse [24]. This could be documented in a dementia-
specific advance directive.
Although it is expected in national policies that health-
care professionals and specifically GPs will provide ACP 
support within their existing roles [25], qualitative studies 
in countries with an established tradition of ACP have 
shown that even in these healthcare systems only a mi-
nority of physicians actually carry out ACP consultations 
on a regular basis. The apparent reasons for this are lack 
of time as well as insufficient knowledge, skills and self-
confidence [26]. Healthcare professionals seem to have 
great concerns implementing ACP in practice for people 
with dementia, expressing uncertainty over the value of 
ACP, grounded in an anxiety to deliver patient choice, 
especially in dementia care [27].
What Is the Ideal Moment to Start an ACP Process?
Patients, their relatives and GPs emphasise that the 
earlier ACP process starts, the easier it is [28], but appar-
ently, there is nevertheless considerable uncertainty about 
when ACP should be initiated, not only among GPs but 
also among patients and their relatives [29, 30]. Triggers 
for offering an ACP process could be experiences of loss, 
such as losing the abilities to work, drive a car or care for 
oneself, as well as transitions like moving to a nursing 
home or becoming dependent on care [31, 32]. As the 
disclosure of a dementia diagnosis is a critical, vulnerable 
moment in the life of the person affected, the ACP process 
may be more appropriately initiated either before symp-
toms of dementia are perceptible or once the patient has 
coped with the new diagnosis and comprehended the 
course of the illness and the potential decisions that may 
need to be made in the future. Generally, it is advisable to 
initiate an ACP process before a deterioration in the 
health status or an acute life-threatening situation, such 
as sepsis, pneumonia or femoral neck fracture, occurs. 
The wrong assumption that engaging in ACP inevita-
bly means that one loses decision-making capacity soon 
after initiating the process is undoubtedly an obstacle to 
ACP. In the “Consensus Definition from a Multidisci-
plinary Delphi Panel,” it is clearly stated that ACP corre-
sponds to a continuum over a longer period of time, that 
it is primarily about preparing individuals for their deci-
sion-making for future treatments in cases of incapability 
of decision-making and later, more specifically, for the 
situation of a no longer existing decision-making capac-
ity and more specific medical treatment [11].
For patients with mild forms of dementia, certain dis-
cussions and making anticipated decisions are possible 
with limited decision-making capacity. However, it will 
in many cases be too late to initiate an ACP consultation 
if this is left until the patient enters a nursing home. In 
Switzerland, 47% of all residents of nursing homes have a 
diagnosis of dementia: of these, 40% have severe, 31% 
moderate and 29% mild dementia [33]. Many people only 
enter a nursing home when their cognitive abilities no 
longer allow them to remain in their own domestic envi-
ronment. It has also been shown that after entering a 
nursing home the moment for initiating ACP is often 
missed [34] or the ACP process is inadequately imple-
mented [35], also clearly hinting at the usefulness of an 
early initiation of the ACP process in healthy days of life.
Conclusions and Recommendations
GPs have undoubtedly an important role in the con-
text of the ACP process for people with dementia. The 
population has a low threshold in accessing GPs; often, 
whole families have a relationship of trust with their GP 
that has developed over many years. In addition, through 
conversations and experiences around different facets of 
health and personal life, GPs are often aware of the values 
and treatment preferences of patients and their relatives. 
In addition, GPs, as they visit their patients at home, are 
familiar with their social environment. 
In accordance with recently published recommenda-
tions [36], it is certainly one of the GPs’ core responsi-
bilities to incorporate ACP into primary care before de-
mentia robs patients of their decision-making capacity 
[37–39]. If dementia has already been diagnosed, GPs 
should identify the right moments to initiate an ACP pro-
cess. This includes the period after coping with the diag-
nosis [12], experiences of loss, any transitions and, of 
course, any deterioration in health status or a life-threat-
ening situation. 
It is not necessary that GPs assume the full responsibil-
ity for the actual ACP consultation. Other healthcare pro-











































































ers or chaplaincy, often have even better conditions to 
perform this task if trained in ACP-specific skills. What 
is important is that these healthcare professionals com-
municate closely with the responsible GP and that pa-
tients and their relatives have confidence in their ACP 
facilitator. 
Even if GPs assign the ACP conversation to specially 
trained professionals, it is of utmost importance that they 
have access to the documents generated in the ACP pro-
cess as early as possible. It will generally be the GP’s task, 
as coordinator of the healthcare professionals involved in 
the treatment, to make the results of the ACP process and 
the relevant documents accessible to all those involved in 
the patient’s treatment and care, while ensuring that the 
usual rules of confidentiality are observed [40].
The noblest functions of GPs include implementing 
the declarations made by the patient, his or her treatment 
preferences, the wishes set down in the documentation 
and the order in the medical emergency plans. Since not 
all imaginable situations in the course of the illness can be 
anticipated, it will sometimes be unavoidable, despite the 
exemplary implementation of ACP, to consult with the 
surrogate appointed by the patient and all the healthcare 
professionals involved in order to do justice to the “pre-
sumed will” of the patient [41]. To minimise the burden 
on relatives, particularly in countries where legislation 
transfers a high degree of responsibility to them for deci-
sions made at the end of life, it is important that these 
decisions are ultimately backed up by the whole team in-
volved in the treatment.
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